|
TRIM32 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.420200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438750E-01 |
| Normal-vs-Stage2 |
1.318290E-02 |
| Normal-vs-Stage3 |
8.45000000000429E-05 |
| Normal-vs-Stage4 |
7.842500E-03 |
| Stage1-vs-Stage2 |
1.737850E-01 |
| Stage1-vs-Stage3 |
7.040000E-04 |
| Stage1-vs-Stage4 |
6.101900E-02 |
| Stage2-vs-Stage3 |
2.381000E-01 |
| Stage2-vs-Stage4 |
5.926000E-01 |
| Stage3-vs-Stage4 |
6.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.844800E-03 |
| Normal-vs-AfricanAmerican |
1.785590E-01 |
| Normal-vs-Asian |
9.031400E-01 |
| Caucasian-vs-AfricanAmerican |
6.928600E-01 |
| Caucasian-vs-Asian |
3.141000E-01 |
| AfricanAmerican-vs-Asian |
5.307800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.990200E-04 |
| Normal-vs-Female |
1.222610E-01 |
| Male-vs-Female |
3.518100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.156400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.853800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.182900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.311800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.505200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.048200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.833600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.176100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.862400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.663600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.788600E-01 |
| Normal-vs-Grade 2 |
2.044600E-01 |
| Normal-vs-Grade 3 |
6.027200E-04 |
| Normal-vs-Grade 4 |
3.88599999999739E-05 |
| Grade 1-vs-Grade 2 |
2.004600E-01 |
| Grade 1-vs-Grade 3 |
3.536300E-02 |
| Grade 1-vs-Grade 4 |
5.764900E-03 |
| Grade 2-vs-Grade 3 |
6.621500E-03 |
| Grade 2-vs-Grade 4 |
1.770610E-04 |
| Grade 3-vs-Grade 4 |
9.562400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.342400E-01 |
| Normal-vs-ccB subtype |
3.701800E-03 |
| ccA subtype-vs-ccB subtype |
2.908400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.178100E-02 |
| Normal-vs-N1 |
1.710980E-01 |
| N0-vs-N1 |
6.012200E-01 |
|
|
